bupivacaine hydrochloride monohydrate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
Pfizer (Australia) BUPIVACAINE HYDROCHLORIDE 0.5% (50mg/10mL) injection BP ampoule
AUST R: 11312
Active ingredients:
bupivacaine hydrochloride monohydrate

Dosage form:
Injection, solution

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800-675-229

From
17 Dec 2024
to
16 May 2025

Shortage status:
Current

Availability:
Unavailable

Reason:
Unexpected increase in consumer demand

Management action:
The sponsor is working to expedite the next shipment. Alternative generic products are available.
BUPIVADREN Bupivacaine 0.5% w/v with Adrenaline (epinephrine) 1:200,000 injection solution vial
AUST R: 292528
Active ingredients:
adrenaline (epinephrine) acid tartrate
bupivacaine hydrochloride monohydrate

Dosage form:
Injection, solution

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800-675-229

Deletion from market:
31 Jan 2025

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative generic products are available.
Pfizer (Australia) BUPIVACAINE HYDROCHLORIDE 0.5% (100mg/20mL) injection BP vial
AUST R: 12725
Active ingredients:
bupivacaine hydrochloride monohydrate

Dosage form:
Injection, solution

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800-675-229

Deletion from market:
31 Jan 2024

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability